Myriad Genetics Inc (MYGN)

Free Cash Flow Growth

80.54%

TTM · Period ending:

MYGN logo

MYGN Free Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported80.54%
MYGN TTM Free Cash Flow YoY % (26.73% → 80.54%)
High-resolution chart · PNG

MYGN free cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Myriad Genetics Inc Free Cash Flow Growth — Trailing twelve months (TTM)
Period endingFree Cash Flow Growth
80.543%
28.8973%
39.8119%
77.0833%
67.8779%
82.9994%
82.6819%
27.115%
-15.4362%
0.7697%
-21.1842%
3.2867%
27.6699%
-32.9071%
-76,100%
-1,886.1111%
-541.2451%
-1,186.1111%
100.4988%
70.8502%
-150.8911%
-79.6226%
-193.911%
-129.759%
-32.7563%
-41.8222%
-55.6133%
-9.8806%
-30.1395%
-6.372%
-25.0195%
-27.1361%
7.3926%
-17.8209%
3.4677%
-13.4247%
-44.1406%
-31.9732%
-19.6626%
-2.6336%
53.6233%
67.4917%
75.1796%
73.9043%
-33.7003%
-47.9999%
-61.0075%
-56.6305%
8.2767%
40.797%
55.9911%
31.6978%
23.3035%
12.7097%
27.6746%
19.9595%
6.7354%
-7.5405%
-25.0246%
-18.0969%
-16.5301%
2.558%
52.4536%
48.5211%
93.3139%
-13.2293%
-32.9358%
2.7267%
-15.0387%
851.6674%
601.6234%
376.2908%
341.768%
48.9507%
31.4675%
10.2747%
-4.3241%
-19.4949%
-29.2952%
-38.5492%
-18.8648%
3.9178%
-12.201%
9.0201%
13.5863%
-14.45%
33.5408%
33.7077%
36.3035%
40.9623%
-9.6055%
-44.4863%
-135.599%
-149.1028%
-207.5378%
-159.6661%
-156.5166%
-169.4851%
-57.5913%
-750.5387%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.